Bio-Butadiene Market by Application (Resins, Synthetic Rubber), Source (Biobutanol, Bioethanol), End Use, Technology, Purity Grade - Global Forecast 2025-2032
Description
The Bio-Butadiene Market was valued at USD 75.76 million in 2024 and is projected to grow to USD 81.03 million in 2025, with a CAGR of 6.87%, reaching USD 128.91 million by 2032.
A strategic framing of bio-based butadiene that integrates feedstock evolution, decarbonization incentives, and industrial adoption dynamics for decision-making
The introduction positions bio-based butadiene as an emergent nexus between chemical innovation and decarbonization priorities. As industry players re-evaluate feedstock strategies, the shift from fossil-derived intermediates toward bio-derived alternatives has accelerated adoption discussions across polymer and elastomer value chains. This document synthesizes technical, commercial, and regulatory dimensions that shape the bio-butadiene landscape and highlights the tangible inflection points where biology-enabled production methods intersect with traditional petrochemical routes.
In framing the context, it is important to recognize how catalytic and fermentation-based processes are converging with existing infrastructure to lower barriers to integration. Investment patterns and strategic partnerships increasingly favor companies that can demonstrate both technical scalability and supply-chain compatibility. With that in mind, this introduction outlines core drivers including feedstock diversification, lifecycle carbon considerations, and product performance parity that together define near-term industry priorities.
Finally, the introduction establishes the lens for subsequent analysis by emphasizing decision-relevant intelligence. The following sections explore transformative shifts, policy impacts, segmentation nuances, regional dynamics, competitive positioning, and action-oriented recommendations designed to inform executives, technologists, and commercial strategists seeking to translate emerging opportunities into competitive advantage.
How feedstock innovation, catalytic breakthroughs, and procurement policies are converging to accelerate commercial adoption and reshape supply-chain relationships
Transformative shifts are reconfiguring the bio-butadiene space as advances in feedstock flexibility, catalytic pathways, and off-take alignment re-shape value propositions across the supply chain. New catalytic dehydration and fermentation-coupled routes are achieving improved yields and energy efficiencies, enabling producers to reduce dependency on traditional naphtha cracking. Concurrently, major downstream customers are increasing technical engagement to ensure bio-derived monomers meet established processing and quality specifications, which reduces adoption friction and accelerates co-development agreements.
Regulatory momentum and corporate decarbonization commitments have amplified the strategic value of bio-derived intermediates. Incentive structures and low-carbon procurement frameworks are prompting manufacturers to reassess sourcing strategies, while voluntary purchasing by large OEMs and polymer makers is creating early anchor demand. At the same time, investors are selectively funding scale-up projects that pair process intensification with feedstock security, favoring ventures that demonstrate compatibility with existing asset footprints and logistics.
Taken together, these shifts produce a cascade effect: process innovations enable cost and carbon improvements, customer co-development reduces technical risk, and policy signals de-risk commercial commitments. As the industry moves from pilot to demonstration to early commercial stages, the ecosystem's ability to connect advanced production technologies with validated end-use performance will determine which players capture first-mover advantages and long-term partnerships.
Comprehensive effects of the 2025 tariff changes that compelled procurement diversification, nearshoring, and strategic supply-chain realignment across the chemical value chain
The introduction of tariffs targeted at selected chemical imports in 2025 has materially altered trade flows and procurement strategies for manufacturers reliant on cross-border intermediates. Tariff adjustments have prompted buyers to re-evaluate long-standing sourcing relationships, prioritize regional supply continuity, and accelerate conversations with domestic producers and alternate feedstock suppliers. These dynamics have intensified the focus on nearshoring and flexible manufacturing configurations to mitigate exposure to tariff-induced cost volatility.
In response, companies have pursued several adaptive measures. Procurement teams are diversifying supplier portfolios and structuring longer-term offtake agreements to secure predictable supply while insulating margin profiles from sudden duty shifts. Capital allocation has shifted toward projects that can capitalize on regional demand or that provide strategic insulation through vertical integration. Additionally, firms are investing in enhanced customs and tax expertise to optimize tariff classifications and utilize trade remedy mechanisms where applicable.
The cumulative impact extends beyond immediate cost implications; tariffs have catalyzed structural shifts in supply-chain architecture. Organizations are accelerating qualification of regionally sourced bio-butadiene and related intermediates, emphasizing compatibility testing and logistics readiness. As a result, the tariff environment of 2025 has acted as a forcing function, bringing forward decisions that would otherwise have unfolded over a longer horizon and reshaping competitive dynamics among global and regional producers.
Deep segmentation insights explaining how application, feedstock source, end-use needs, production technology, and purity grade collectively determine strategic positioning
Segmentation analysis reveals differentiated performance and demand characteristics across application, source, end use, technology, and purity dimensions. In applications, the landscape divides between resins and synthetic rubber where resins encompass acrylonitrile butadiene styrene and styrene acrylonitrile, and synthetic rubber spans butadiene rubber, nitrile butadiene rubber, and styrene butadiene rubber; resin users typically prioritize thermal stability and dimensional control whereas synthetic rubber customers emphasize elastomeric performance and processability, driving distinct qualification pathways and supplier engagement models.
Across sources, producers are distinguishing offerings derived from biobutanol versus bioethanol feedstocks; biobutanol-derived streams often yield fewer downstream impurities and can be favored where downstream polymerization sensitivity is high, while routes from bioethanol benefit from broader feedstock availability and established fermentation infrastructure, influencing where scaling investments are directed. End-use segmentation shows diverging timelines and technical thresholds: automotive applications demand rigorous performance validation and long-term supply assurance, construction sectors value material durability and cost predictability, and consumer goods prioritize consistency and regulatory compliance for contact and safety standards.
From a technology standpoint, catalytic cracking and catalytic dehydration represent competing pathways with differences in capital intensity, unit complexity, and integration options. Purity grade segmentation, which separates chemical grade, polymer grade, and ultra-high purity, further conditions commercial trajectories because buyers’ tolerance for impurity profiles determines the extent of finishing, blending, or onsite purification that producers must provide. Understanding these layered segmentation dynamics is essential for aligning R&D, commercial outreach, and capacity planning with the nuanced requirements of each downstream cohort.
Regional competitive and policy landscapes that determine strategic market entry, partnership models, and commercialization pathways across global jurisdictions
Regional dynamics are creating uneven opportunities and tactical considerations across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each shaped by distinct policy, feedstock, and industrial ecosystems. In the Americas, a combination of feedstock diversity and proximity to major polymer and rubber manufacturers supports a strong case for localized production and integration, while regional incentives and procurement preferences drive collaboration between technology providers and OEMs to validate bio-derived intermediates.
Europe, the Middle East & Africa region features a layered policy environment where regulatory incentives, low-carbon frameworks, and industrial decarbonization targets intersect to make bio-derived monomers strategically attractive. Companies in this region frequently adopt rigorous lifecycle assessment frameworks and are active in developing certification pathways that support sustainable sourcing claims, reinforcing demand signals for compliant suppliers. In contrast, the Asia-Pacific region combines scale advantages, abundant fermentation feedstocks, and rapidly maturing downstream manufacturing, making it a focal point for both large-scale production projects and commercial piloting. Asia-Pacific buyers emphasize cost competitiveness and logistical efficiency, yet leading manufacturers are also signaling commitments to lower-carbon inputs as a differentiator in export markets.
Taken together, these regional distinctions require producers and investors to tailor entry strategies, partnership models, and technical dossiers to local regulatory expectations, industrial partner needs, and logistics realities. Effective regional strategies will marry global technology capabilities with localized commercialization plans to capture demand where policy and industry alignment are strongest.
Competitive dynamics driven by technology leadership, integrated partnerships, and flexible commercial models that accelerate qualification and scale-up
Competitive insights underscore a landscape where technology specialization, strategic partnerships, and supply-chain integration shape differentiation. Leading companies combine proprietary catalysts, process intensification know-how, and partnerships with downstream polymer makers to accelerate qualification and secure early contracts. Strategic alliances between feedstock producers, technology licensors, and commodity buyers are increasingly common as firms seek to de-risk scale-up by aligning process development with guaranteed product off-take and co-investment arrangements.
On the technology front, players who can demonstrate reproducible quality across variable feedstock inputs gain a commercial edge because downstream processors require consistent impurity profiles and predictable behavior in polymerization reactors. Additionally, companies that invest in modular and retrofit-capable plant designs can access incremental demand more rapidly and with lower capital exposure. Competitive differentiation also emerges from the ability to offer multiple purity grades and tailored logistics solutions that reduce customer qualification timelines.
Finally, market entrants and incumbents alike are leveraging intellectual property portfolios, pilot-scale validation data, and joint development agreements to move beyond proofs of concept. Those that synchronize technical credibility with customer-centric commercial models-such as tolling, joint ventures, or long-term strategic supply agreements-are best positioned to convert technological promise into durable commercial relationships.
Actionable strategic moves for leaders to accelerate commercialization, mitigate scale-up risk, and secure differentiated commercial positions across value chains
Industry leaders should pursue a coordinated set of actions to capture near-term opportunities while managing scale-up risks. First, prioritize co-development agreements with key downstream customers to shorten qualification cycles and embed product specifications into early design criteria; this approach reduces technical friction and creates tangible demand signals that support investment decisions. Second, diversify feedstock and technology exposures by piloting both biobutanol- and bioethanol-derived routes and by assessing catalytic dehydration and catalytic cracking pathways to balance capital intensity against operational flexibility.
Additionally, invest in supply-chain resilience by developing regional sourcing hubs, qualifying multiple logistics providers, and establishing contingency feedstock agreements that can absorb tariff-induced or geopolitical disruptions. Complement these moves with targeted investments in purification technologies to offer differentiated purity grades that address distinct end-use needs. From a commercial perspective, adopt flexible contracting frameworks-such as tolling arrangements or staged offtake commitments-that lower barriers for buyers to trial bio-derived inputs while preserving upside for producers.
Finally, strengthen stakeholder engagement by documenting lifecycle performance, pursuing credible certification where applicable, and transparently communicating technical capabilities. These actions, taken together, will enable leaders to translate technical advantage into negotiated commercial terms and durable customer relationships while maintaining the optionality needed to adapt as the industrial and policy landscapes evolve.
A transparent, multi-source research methodology combining primary expert interviews, technical validation, and triangulated secondary analysis to ensure actionable insights
The research underpinning this analysis combined primary interviews with industry technologists, procurement leads, and policy experts together with an extensive review of technical literature and company disclosures to validate technology claims and commercial intents. Technical assessments evaluated comparative process pathways, impurity profiles, and integration complexity across catalytic and fermentation-derived routes, while commercial analysis focused on supply-chain configurations, contracting practices, and regional policy impacts.
Primary engagement included structured interviews and follow-up discussions to probe qualification timelines, purity requirements, and risk tolerances among downstream users. Secondary research complemented these conversations by compiling material property data, patent activity, and public capital allocation announcements to contextualize strategic moves. Triangulation of data sources ensured that assertions about technology maturity, supply-chain behaviors, and regional regulatory drivers were corroborated from multiple perspectives.
Finally, the methodology emphasizes transparency in assumptions and traceability of sources. Where expert judgment was applied, rationale is documented and sensitivity around technical constraints and regulatory shifts is clearly delineated so readers can adapt insights to their internal planning scenarios. This methodological rigor supports pragmatic recommendations and actionable takeaways suitable for executive decision-making.
Concluding perspective on how technical validation, customer partnerships, and regional strategies combine to determine leadership in the evolving bio-based butadiene landscape
In conclusion, bio-based butadiene represents a strategically significant opportunity that intersects decarbonization ambitions, feedstock diversification, and downstream performance requirements. The ecosystem is progressing from demonstration to early commercial engagement driven by catalytic and fermentation advances, growing buyer interest in low-carbon inputs, and policy frameworks that encourage alternative feedstocks. While technical and logistical challenges remain, the current trajectory favors actors who can couple reliable product quality with customer-centric commercial models and regional go-to-market strategies.
Executives should recognize that success will depend on integrating technical validation with commercial commitments. Companies that invest in co-development, modular capacity, and flexible contracting will be better able to convert early interest into enduring supply relationships. Moreover, regional strategies that align production siting with policy incentives, feedstock availability, and downstream clusters will materially influence competitive outcomes.
Ultimately, the next 24 to 36 months will be a decisive period in which partnerships, pilot outcomes, and procurement decisions create lasting advantages. Firms that move deliberately, prioritize technical credibility, and structure commercial terms to lower buyer risk will be positioned to lead as the industry scales.
Note: PDF & Excel + Online Access - 1 Year
A strategic framing of bio-based butadiene that integrates feedstock evolution, decarbonization incentives, and industrial adoption dynamics for decision-making
The introduction positions bio-based butadiene as an emergent nexus between chemical innovation and decarbonization priorities. As industry players re-evaluate feedstock strategies, the shift from fossil-derived intermediates toward bio-derived alternatives has accelerated adoption discussions across polymer and elastomer value chains. This document synthesizes technical, commercial, and regulatory dimensions that shape the bio-butadiene landscape and highlights the tangible inflection points where biology-enabled production methods intersect with traditional petrochemical routes.
In framing the context, it is important to recognize how catalytic and fermentation-based processes are converging with existing infrastructure to lower barriers to integration. Investment patterns and strategic partnerships increasingly favor companies that can demonstrate both technical scalability and supply-chain compatibility. With that in mind, this introduction outlines core drivers including feedstock diversification, lifecycle carbon considerations, and product performance parity that together define near-term industry priorities.
Finally, the introduction establishes the lens for subsequent analysis by emphasizing decision-relevant intelligence. The following sections explore transformative shifts, policy impacts, segmentation nuances, regional dynamics, competitive positioning, and action-oriented recommendations designed to inform executives, technologists, and commercial strategists seeking to translate emerging opportunities into competitive advantage.
How feedstock innovation, catalytic breakthroughs, and procurement policies are converging to accelerate commercial adoption and reshape supply-chain relationships
Transformative shifts are reconfiguring the bio-butadiene space as advances in feedstock flexibility, catalytic pathways, and off-take alignment re-shape value propositions across the supply chain. New catalytic dehydration and fermentation-coupled routes are achieving improved yields and energy efficiencies, enabling producers to reduce dependency on traditional naphtha cracking. Concurrently, major downstream customers are increasing technical engagement to ensure bio-derived monomers meet established processing and quality specifications, which reduces adoption friction and accelerates co-development agreements.
Regulatory momentum and corporate decarbonization commitments have amplified the strategic value of bio-derived intermediates. Incentive structures and low-carbon procurement frameworks are prompting manufacturers to reassess sourcing strategies, while voluntary purchasing by large OEMs and polymer makers is creating early anchor demand. At the same time, investors are selectively funding scale-up projects that pair process intensification with feedstock security, favoring ventures that demonstrate compatibility with existing asset footprints and logistics.
Taken together, these shifts produce a cascade effect: process innovations enable cost and carbon improvements, customer co-development reduces technical risk, and policy signals de-risk commercial commitments. As the industry moves from pilot to demonstration to early commercial stages, the ecosystem's ability to connect advanced production technologies with validated end-use performance will determine which players capture first-mover advantages and long-term partnerships.
Comprehensive effects of the 2025 tariff changes that compelled procurement diversification, nearshoring, and strategic supply-chain realignment across the chemical value chain
The introduction of tariffs targeted at selected chemical imports in 2025 has materially altered trade flows and procurement strategies for manufacturers reliant on cross-border intermediates. Tariff adjustments have prompted buyers to re-evaluate long-standing sourcing relationships, prioritize regional supply continuity, and accelerate conversations with domestic producers and alternate feedstock suppliers. These dynamics have intensified the focus on nearshoring and flexible manufacturing configurations to mitigate exposure to tariff-induced cost volatility.
In response, companies have pursued several adaptive measures. Procurement teams are diversifying supplier portfolios and structuring longer-term offtake agreements to secure predictable supply while insulating margin profiles from sudden duty shifts. Capital allocation has shifted toward projects that can capitalize on regional demand or that provide strategic insulation through vertical integration. Additionally, firms are investing in enhanced customs and tax expertise to optimize tariff classifications and utilize trade remedy mechanisms where applicable.
The cumulative impact extends beyond immediate cost implications; tariffs have catalyzed structural shifts in supply-chain architecture. Organizations are accelerating qualification of regionally sourced bio-butadiene and related intermediates, emphasizing compatibility testing and logistics readiness. As a result, the tariff environment of 2025 has acted as a forcing function, bringing forward decisions that would otherwise have unfolded over a longer horizon and reshaping competitive dynamics among global and regional producers.
Deep segmentation insights explaining how application, feedstock source, end-use needs, production technology, and purity grade collectively determine strategic positioning
Segmentation analysis reveals differentiated performance and demand characteristics across application, source, end use, technology, and purity dimensions. In applications, the landscape divides between resins and synthetic rubber where resins encompass acrylonitrile butadiene styrene and styrene acrylonitrile, and synthetic rubber spans butadiene rubber, nitrile butadiene rubber, and styrene butadiene rubber; resin users typically prioritize thermal stability and dimensional control whereas synthetic rubber customers emphasize elastomeric performance and processability, driving distinct qualification pathways and supplier engagement models.
Across sources, producers are distinguishing offerings derived from biobutanol versus bioethanol feedstocks; biobutanol-derived streams often yield fewer downstream impurities and can be favored where downstream polymerization sensitivity is high, while routes from bioethanol benefit from broader feedstock availability and established fermentation infrastructure, influencing where scaling investments are directed. End-use segmentation shows diverging timelines and technical thresholds: automotive applications demand rigorous performance validation and long-term supply assurance, construction sectors value material durability and cost predictability, and consumer goods prioritize consistency and regulatory compliance for contact and safety standards.
From a technology standpoint, catalytic cracking and catalytic dehydration represent competing pathways with differences in capital intensity, unit complexity, and integration options. Purity grade segmentation, which separates chemical grade, polymer grade, and ultra-high purity, further conditions commercial trajectories because buyers’ tolerance for impurity profiles determines the extent of finishing, blending, or onsite purification that producers must provide. Understanding these layered segmentation dynamics is essential for aligning R&D, commercial outreach, and capacity planning with the nuanced requirements of each downstream cohort.
Regional competitive and policy landscapes that determine strategic market entry, partnership models, and commercialization pathways across global jurisdictions
Regional dynamics are creating uneven opportunities and tactical considerations across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each shaped by distinct policy, feedstock, and industrial ecosystems. In the Americas, a combination of feedstock diversity and proximity to major polymer and rubber manufacturers supports a strong case for localized production and integration, while regional incentives and procurement preferences drive collaboration between technology providers and OEMs to validate bio-derived intermediates.
Europe, the Middle East & Africa region features a layered policy environment where regulatory incentives, low-carbon frameworks, and industrial decarbonization targets intersect to make bio-derived monomers strategically attractive. Companies in this region frequently adopt rigorous lifecycle assessment frameworks and are active in developing certification pathways that support sustainable sourcing claims, reinforcing demand signals for compliant suppliers. In contrast, the Asia-Pacific region combines scale advantages, abundant fermentation feedstocks, and rapidly maturing downstream manufacturing, making it a focal point for both large-scale production projects and commercial piloting. Asia-Pacific buyers emphasize cost competitiveness and logistical efficiency, yet leading manufacturers are also signaling commitments to lower-carbon inputs as a differentiator in export markets.
Taken together, these regional distinctions require producers and investors to tailor entry strategies, partnership models, and technical dossiers to local regulatory expectations, industrial partner needs, and logistics realities. Effective regional strategies will marry global technology capabilities with localized commercialization plans to capture demand where policy and industry alignment are strongest.
Competitive dynamics driven by technology leadership, integrated partnerships, and flexible commercial models that accelerate qualification and scale-up
Competitive insights underscore a landscape where technology specialization, strategic partnerships, and supply-chain integration shape differentiation. Leading companies combine proprietary catalysts, process intensification know-how, and partnerships with downstream polymer makers to accelerate qualification and secure early contracts. Strategic alliances between feedstock producers, technology licensors, and commodity buyers are increasingly common as firms seek to de-risk scale-up by aligning process development with guaranteed product off-take and co-investment arrangements.
On the technology front, players who can demonstrate reproducible quality across variable feedstock inputs gain a commercial edge because downstream processors require consistent impurity profiles and predictable behavior in polymerization reactors. Additionally, companies that invest in modular and retrofit-capable plant designs can access incremental demand more rapidly and with lower capital exposure. Competitive differentiation also emerges from the ability to offer multiple purity grades and tailored logistics solutions that reduce customer qualification timelines.
Finally, market entrants and incumbents alike are leveraging intellectual property portfolios, pilot-scale validation data, and joint development agreements to move beyond proofs of concept. Those that synchronize technical credibility with customer-centric commercial models-such as tolling, joint ventures, or long-term strategic supply agreements-are best positioned to convert technological promise into durable commercial relationships.
Actionable strategic moves for leaders to accelerate commercialization, mitigate scale-up risk, and secure differentiated commercial positions across value chains
Industry leaders should pursue a coordinated set of actions to capture near-term opportunities while managing scale-up risks. First, prioritize co-development agreements with key downstream customers to shorten qualification cycles and embed product specifications into early design criteria; this approach reduces technical friction and creates tangible demand signals that support investment decisions. Second, diversify feedstock and technology exposures by piloting both biobutanol- and bioethanol-derived routes and by assessing catalytic dehydration and catalytic cracking pathways to balance capital intensity against operational flexibility.
Additionally, invest in supply-chain resilience by developing regional sourcing hubs, qualifying multiple logistics providers, and establishing contingency feedstock agreements that can absorb tariff-induced or geopolitical disruptions. Complement these moves with targeted investments in purification technologies to offer differentiated purity grades that address distinct end-use needs. From a commercial perspective, adopt flexible contracting frameworks-such as tolling arrangements or staged offtake commitments-that lower barriers for buyers to trial bio-derived inputs while preserving upside for producers.
Finally, strengthen stakeholder engagement by documenting lifecycle performance, pursuing credible certification where applicable, and transparently communicating technical capabilities. These actions, taken together, will enable leaders to translate technical advantage into negotiated commercial terms and durable customer relationships while maintaining the optionality needed to adapt as the industrial and policy landscapes evolve.
A transparent, multi-source research methodology combining primary expert interviews, technical validation, and triangulated secondary analysis to ensure actionable insights
The research underpinning this analysis combined primary interviews with industry technologists, procurement leads, and policy experts together with an extensive review of technical literature and company disclosures to validate technology claims and commercial intents. Technical assessments evaluated comparative process pathways, impurity profiles, and integration complexity across catalytic and fermentation-derived routes, while commercial analysis focused on supply-chain configurations, contracting practices, and regional policy impacts.
Primary engagement included structured interviews and follow-up discussions to probe qualification timelines, purity requirements, and risk tolerances among downstream users. Secondary research complemented these conversations by compiling material property data, patent activity, and public capital allocation announcements to contextualize strategic moves. Triangulation of data sources ensured that assertions about technology maturity, supply-chain behaviors, and regional regulatory drivers were corroborated from multiple perspectives.
Finally, the methodology emphasizes transparency in assumptions and traceability of sources. Where expert judgment was applied, rationale is documented and sensitivity around technical constraints and regulatory shifts is clearly delineated so readers can adapt insights to their internal planning scenarios. This methodological rigor supports pragmatic recommendations and actionable takeaways suitable for executive decision-making.
Concluding perspective on how technical validation, customer partnerships, and regional strategies combine to determine leadership in the evolving bio-based butadiene landscape
In conclusion, bio-based butadiene represents a strategically significant opportunity that intersects decarbonization ambitions, feedstock diversification, and downstream performance requirements. The ecosystem is progressing from demonstration to early commercial engagement driven by catalytic and fermentation advances, growing buyer interest in low-carbon inputs, and policy frameworks that encourage alternative feedstocks. While technical and logistical challenges remain, the current trajectory favors actors who can couple reliable product quality with customer-centric commercial models and regional go-to-market strategies.
Executives should recognize that success will depend on integrating technical validation with commercial commitments. Companies that invest in co-development, modular capacity, and flexible contracting will be better able to convert early interest into enduring supply relationships. Moreover, regional strategies that align production siting with policy incentives, feedstock availability, and downstream clusters will materially influence competitive outcomes.
Ultimately, the next 24 to 36 months will be a decisive period in which partnerships, pilot outcomes, and procurement decisions create lasting advantages. Firms that move deliberately, prioritize technical credibility, and structure commercial terms to lower buyer risk will be positioned to lead as the industry scales.
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
183 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Advancements in enzymatic fermentation processes for high-yield bio-butadiene production
- 5.2. Scaling up cell-based bio-butadiene synthesis with continuous bioreactor optimization strategies
- 5.3. Integration of lignocellulosic biomass valorization pathways in bio-butadiene manufacturing
- 5.4. Emerging catalytic dehydration technologies for turning bio-derived butanediol into butadiene
- 5.5. Life cycle assessment of bio-butadiene supply chains to inform sustainable investment decisions
- 5.6. Strategic partnerships between biochemical startups and petrochemical incumbents to commercialize bio-butadiene
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Bio-Butadiene Market, by Application
- 8.1. Resins
- 8.1.1. Acrylonitrile Butadiene Styrene
- 8.1.2. Styrene Acrylonitrile
- 8.2. Synthetic Rubber
- 8.2.1. Butadiene Rubber
- 8.2.2. Nitrile Butadiene Rubber
- 8.2.3. Styrene Butadiene Rubber
- 9. Bio-Butadiene Market, by Source
- 9.1. Biobutanol
- 9.2. Bioethanol
- 10. Bio-Butadiene Market, by End Use
- 10.1. Automotive
- 10.2. Construction
- 10.3. Consumer Goods
- 11. Bio-Butadiene Market, by Technology
- 11.1. Catalytic Cracking
- 11.2. Catalytic Dehydration
- 12. Bio-Butadiene Market, by Purity Grade
- 12.1. Chemical Grade
- 12.2. Polymer Grade
- 13. Bio-Butadiene Market, by Region
- 13.1. Americas
- 13.1.1. North America
- 13.1.2. Latin America
- 13.2. Europe, Middle East & Africa
- 13.2.1. Europe
- 13.2.2. Middle East
- 13.2.3. Africa
- 13.3. Asia-Pacific
- 14. Bio-Butadiene Market, by Group
- 14.1. ASEAN
- 14.2. GCC
- 14.3. European Union
- 14.4. BRICS
- 14.5. G7
- 14.6. NATO
- 15. Bio-Butadiene Market, by Country
- 15.1. United States
- 15.2. Canada
- 15.3. Mexico
- 15.4. Brazil
- 15.5. United Kingdom
- 15.6. Germany
- 15.7. France
- 15.8. Russia
- 15.9. Italy
- 15.10. Spain
- 15.11. China
- 15.12. India
- 15.13. Japan
- 15.14. Australia
- 15.15. South Korea
- 16. Competitive Landscape
- 16.1. Market Share Analysis, 2024
- 16.2. FPNV Positioning Matrix, 2024
- 16.3. Competitive Analysis
- 16.3.1. Asahi Kasei Corp.
- 16.3.2. Axens
- 16.3.3. BASF SE
- 16.3.4. Biokemik
- 16.3.5. Dow Inc.
- 16.3.6. ETB Catalytic Technologies
- 16.3.7. Evonik Industries AG
- 16.3.8. Genomatica
- 16.3.9. Global Bioenergies
- 16.3.10. LG Chemicals
- 16.3.11. Mitsubishi Chemical Corporation
- 16.3.12. SABIC
- 16.3.13. Synthos S.A.
- 16.3.14. Toray Industries, Inc.
- 16.3.15. Trinseo
- 16.3.16. Versalis
- 16.3.17. Zeon Corporation
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
